Speakers

Tristan Clark, BM, MRCP, DTM&H, MD
Associate Professor and Consultant in Infectious Diseases, University of Southampton Faculty of Medicine and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
 

Dr Tristan Clark is an Associate Professor at the University of Southampton and an Honorary Consultant Physician in Infectious Diseases at University Hospital Southampton. Dr Clark conducts clinical research in influenza and other respiratory viruses and has designed and conducted clinical trials of vaccines, antivirals and in-vitro diagnostic devices. He is the holder of an NIHR post-doctoral fellowship and is recognised as a key opinion leader in the evaluation of the clinical impact of rapid in-vitro diagnostic tests for infection.  He has published the results of his trials in the New England Journal of Medicine and Lancet series journals and has received grant funding from the Department of Health, National Institute for Health Research (NIHR), European Union, Research Councils, several charities and industry. He is a member of the scientific affairs committee for the British Infection Society and the NIHR Pandemic Influenza studies board and contributes to national policy documents on influenza and point-of-care testing. He is an associate editor for the Journal of Infection and Current Opinion in Infectious Diseases.

 

Disclosures: Receives consulting fees from Roche, Biofire LLC, BioMerieux, Synairgen. Receives fees for non-CME/CE services directly from Biofire LLC, BioMerieux. Does contracted research for NIHR.

 

 

Marc Roger Couturier, PhD, D(ABMM)
Medical Director, ARUP Laboratories, Associate Professor of Pathology, University of Utah, Salt Lake City, UT 

Dr. Couturier is an associate professor of pathology at the University of Utah School of Medicine. He received his PhD in medical microbiology and immunology with a specialty in bacteriology from the University of Alberta in Edmonton, Alberta, Canada. Dr. Couturier served as a research associate at the Alberta Provincial Laboratory for Public Health and completed a medical microbiology fellowship (ABMM) at the University of Utah. His research interests include improved diagnostics for emerging agents of infectious gastroenteritis and improving/modernizing diagnostic parasitology testing including the use of artificial intelligence and digital imaging. He is board certified in medical microbiology, a member of the American Society for Microbiology and European Society for Clinical Microbiology and Infectious Disease, a CLIAC representative, and a member of the College of American Pathologists microbiology resource committee.

 

Disclosures: Has ownership Interest less than 5% in BioMerieux. Spouse is employed by BioFire Diagnostics.

 

 

  Sue Gerber, MD
CDC, Atlanta, GA 

Dr. Susan Gerber is Chief of the Respiratory Viruses Branch in the Division of Viral Diseases, National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC). Dr. Gerber started at CDC in 2012 as Team Lead for the Respiratory Virus and Picornavirus Team in the Division of Viral Diseases. She went to medical school at Loyola University Chicago Stritch School of Medicine; and she completed a pediatric residency, chief residency, and pediatric infectious diseases fellowship at the University of Chicago. Dr. Gerber has 14 years of experience in local public health with work on communicable diseases at the Cook County Department of Public Health and the Chicago Department of Public Health. Dr. Gerber is board certified in Pediatrics and Pediatric Infectious Diseases.

 

Disclosures: I have no real or apparent conflicts of interest to report.

 

 

 Alex Greninger MD, PhD, MS, MPhil
University of Washington, Seattle, WA

Alex Greninger is an assistant professor of laboratory medicine and associate director of the clinical virology laboratory at the University of Washington.  He received a BS and MS in Biological Sciences and a BA in International Relations from Stanford University, an MPhil in Epidemiology at Cambridge University, and his MD and PhD from the University of California San Francisco, followed by residency in clinical pathology at the University of Washington. His work generally involves genomically-informed approaches to understanding a variety of infectious diseases.

 

Disclosures: Receives consulting fees from Abbott Molecular.

 

 

Amanda T. Harrington, PhD, D(ABMM)
Loyola University Chicago, Maywood, IL 

Amanda Harrington is an Associate Professor in the Department of Pathology and Laboratory Medicine at Loyola University Chicago and Medical Director of the Clinical Microbiology Laboratory at Loyola University Medical Center in Maywood, IL. She earned her doctoral degree in microbiology from the University of Kansas, did her post-doctoral fellowship training in clinical microbiology at the University of Washington in Seattle, WA, and she is a diplomate of the American Board of Medical Microbiology. She is a member of the Association for Molecular Pathology, American Society for Clinical Pathology, Infectious Disease Society of American, and the South Central Association for Clinical Microbiology.  She is currently serving as the President and branch representative to the Council on Microbial Sciences for the Illinois Society for Microbiology, as well as being an active member of the American Society for Microbiology. 

 

Disclosures: Receives consulting fees from BioFire Diagnostics. Does contracted work for BioFire Diagnostics, Beckman Coulter.

 

 

Lea A. Heberlein-Larson, DrPH, CPH, SM(ASCP)CM

Florida Department of Health, Tampa, FL 

Dr. Heberlein-Larson has a Bachelor of Science Degree in Microbiology, a Master of Public Health Degree in Tropical and Communicable Diseases, and a Doctor in Public Health from the University of South Florida.  She is employed by the Florida Department of Health, Bureau of Public Health Laboratories (BPHL) as the Virology Administrator, located in Tampa.  She has over 20 years of experience in the public health laboratory and has held previous positions in environmental virology, the biological defense laboratory, and clinical virology at BPHL-Tampa.  She now supervises all aspects of the virology unit in Tampa and serves as the lead virologist and subject matter expert for the entire BPHL including but not limited to testing for arboviruses, influenza viruses, other respiratory viruses, noroviruses, and measles virus.

 

Disclosures: I have no real or apparent conflicts of interest to report.

 

 


Peter C. Iwen, MS, PhD, D(ABMM), F(AAM)
Nebraska Medical Center, Omaha, NE

Dr. Iwen is a Professor of Medicine in the Department of Pathology and Microbiology at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska; Director of the Nebraska Public Health Laboratory; and UNMC campus Biosafety Officer. He also is director of a Committee on Postgraduate Education Programs (CPEP)-approved fellowship for post-doctoral scientists to qualify for certification as a Diplomat in the American Board of Medical Microbiology (D[ABMM]). Dr. Iwen specializes in clinical microbiology with an undergraduate degree in Bacteriology from North Dakota State University in Fargo and both masters and doctoral degrees in Infectious Diseases and Molecular Diagnostics from UNMC. He holds certification as a D[ABMM] and has been honored as a Fellow by the American Academy of Microbiologists (F[AAM]). His research focuses on the development and evaluation of diagnostic assays for the identification of microbial pathogens with an emphasis in the detection of fungi causing human disease.

 

Disclosures: I have no real or apparent conflicts of interest to report.

 

Amy L. Leber, PhD, D(ABMM)
Nationwide Children’s Hospital, Columbus, OH

Dr. Leber received her PhD from the Ohio State University and did a post-doctoral Fellowship in Clinical and Public Health Microbiology at UCLA Medical Center. She is a diplomate of the American Board of Microbiology and active in the American Society for Microbiology, ASCP, and AMP. She is currently the Senior Director of Clinical Laboratories and the Director of Microbiology at Nationwide Children's Hospital in Columbus Ohio and an Associate Professor of Pathology and Pediatrics at The Ohio State University. She is the editor-in-Chief of the Clinical Microbiology Procedures Handbook. Her research interests include new molecular diagnostics and diagnosis of infectious diseases in pediatric populations.

 

Disclosures: Receives consulting fees from Qiagen and BioFire. Does contracted research for Qiagen and BioFire.

 

 

Erin McElvania, PhD, D(ABMM)
NorthShore University HealthSystem, Evanston, IL

Dr. McElvania received her Ph.D. in Microbiology and Immunology from the University of North Carolina at Chapel Hill.  She completed her fellowship in Medical & Public Health Microbiology at Washington University in St. Louis and is a Diplomate of the American Board of Medical Microbiology.  Dr. McElvania started her career as Director of Clinical Microbiology at Children’s Medical Center in Dallas, Texas before joining NorthShore University HealthSystem in Evanston, Illinois as their Director of Clinical Microbiology.  She is a Clinical Assistant Professor of Pathology at the University of Chicago Pritzker School of Medicine and her interests include rapid pathogen identification and rapid antimicrobial resistance detection.

 

Disclosures: Receives consulting fees from BD. Receives fees for non-CME/CE services directly from BD. Does contracted research for BD and Luminex. 

 

 

Kristine M. Wylie, PhD
Washington University School of Medicine, St. Louis, MO 

Dr. Kristine Wylie is an Assistant Professor in the Department of Pediatrics and the McDonnell Genome Institute at Washington University School of Medicine. Her laboratory applies innovative methods to study microbes and host response. She has broad experience in microbial genomics studies, which range from characterizing the microbiome and virome in healthy, asymptomatic subjects as part of the Human Microbiome Project to pathogen detection in patient samples.

 

Disclosures: I have no real or apparent conflicts of interest to report.

 

 

Molecular Virology Workshop Organizers

Matthew J. Binnicker, PhD, Mayo Clinic, Rochester, MN
Disclosures: Receives consulting fees from DiaSorin Molecular and Roche Molecular.

 

Randall T. Hayden, MD, St. Jude Children's Hospital, Memphis, TN
Disclosures: Receives consulting fees from Quidel.


Stephanie L. Mitchell, PhD, D(ABMM), University of Pittsburgh Medical Center, Pittsburgh, PA
Disclosures: Receives consulting fees from GenMark Diagnostics and Hologic.
 

Association Management Software Powered by YourMembership  ::  Legal